Article -> Article Details
| Title | Cannabidiol Market Size, Share, Trends, Growth and Outlook Report 2025-2033 |
|---|---|
| Category | Fitness Health --> Health Articles |
| Meta Keywords | Cannabidiol Market |
| Owner | akshaykumar |
| Description | |
| Market Overview The global cannabidiol market size
was valued at USD 7.0 Billion in 2024 and is expected to reach USD 24.4 Billion
by 2033, exhibiting a CAGR of 14.84% during the forecast period of 2025-2033.
North America dominated the market with over 40.4% share in 2024, driven by
growing legalization, product innovations, and increasing consumer awareness of
CBD's health benefits. Study Assumption Years
Cannabidiol Market Key Takeaways
Sample Request Link: https://www.imarcgroup.com/cannabidiol-market/requestsample Market Growth Factors Global cannabidiol sales are driven by increasing consumer
awareness of cannabidiol's medical applications for health and wellness. In
2024, the proportion of Americans who were 18 or older who said they
experienced increased stress or anxiety compared to the same period a year
earlier was 43%. Growing demand for CBD products for the treatment of insomnia,
pain and anxiety associated with sedentary lifestyles and poor diet, a global
regulatory environment that is favorable to growth in the cannabis market for
medical and recreational purposes, and increased acceptance of CBD consumption. Drinking cannabidiol-infused beverages, taking dietary
supplements, and using personal care products for consumption increases market
growth. In the United States, the 2018 Farm Bill drives this growth due to it
legalizing the cultivation of hemp and opening distribution channels. The
veterinary industry continues to profit from these developments. Partnerships
between product developers and retailers have increased the use of CBD for pet
health. R&D continues beyond veterinary use, developing novelized formulations
for recreational or medical purposes. As product innovation is rapidly evolving, companies are
diversifying their product lines into oils, capsules, edibles, topicals and
cosmetics. Daytrip Beverages' CBD/CBN NightTrip gummies (2023), full-spectrum
products such as those of HempMeds Brasil for Brazilian consumers, and Cibdol's
CBD Oil 2.0 spectrum products with multiple cannabinoids for synergistic
properties are prominent examples. They are marketed for multiple physical and
mental health issues including appetite, mood, and sleep, and have driven
market growth. Market Segmentation By Product:
By Source Type:
By Grade:
By Sales Type:
Regional Insights North America dominates the cannabidiol market, accounting
for over 40.4% of the global market share in 2024. The region benefits from
progressive regulations legalizing CBD production and sales, which boost
consumer trust and product innovation. The established cannabis R&D
infrastructure facilitates ongoing product advancements, while high consumer
acceptance and marketing investments continue to propel market growth. Recent Developments & News In November 2024, The Cannabist Company partnered with
Ayurvedic wellness brand Veda Warrior in New Jersey to launch cannabis-infused
cooking essentials, planning to extend to edibles and topicals. October 2024
saw Aurora Cannabis Inc. expand its medical cannabis oil range in Australia
through MedReleaf Australia. In January 2023, Medical Marijuana, Inc.'s
subsidiary HempMeds Brasil released two full-spectrum products in Brazil. In
October 2022, High Tide Inc. launched multi-cannabinoid products via NuLeaf Naturals
in Ontario. In June 2021, The Valens Company acquired Green Roads for
approximately USD 60 Million to enhance supply capabilities. Key Players
If you require any specific information that is not
covered currently within the scope of the report, we will provide the same as a
part of the customization. About Us IMARC Group is a global management consulting firm that
helps the world’s most ambitious changemakers to create a lasting impact. The
company provides a comprehensive suite of market entry and expansion services.
IMARC offerings include thorough market assessment, feasibility studies,
company incorporation assistance, factory setup support, regulatory approvals
and licensing navigation, branding, marketing and sales strategies, competitive
landscape and benchmarking analyses, pricing and cost research, and procurement
research. Contact Us IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: sales@imarcgroup.com Tel No: (D) +91 120 433 0800 United States: +1-201971-6302 | |